Vaccine Manufacturing News - Latest Updates & Headlines
Biological E Limited partners with Bavarian Nordic to increase global access to Chikungunya Vaccine
Hyderabad, February 25: Biological E Limited (BE) on Tuesday announced a strategic partnership with Bavarian Nordic A/S (OMX: BAVA) to expand access to Bavarian Nordic's Chikungunya Vaccine in low-and middle-income countries (LMIC).
Singapore President visits vaccine facility in Bhubaneswar
Bhubaneswar, January 19: Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar, Odisha, which has been established with an investment of Rs 1,500 crore. The plant is expected to have the capacity to produce eight billion doses of vaccines per annum.